|
|
||||||||
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
Department of Microbiology, School of Medicine, Kaohsiung Medical University, 100 Shih-Chuan 1st Road, Kaohsiung 807, Taiwan, ROC
Correspondence Yi-Jing Chen ichich{at}kmu.edu.tw
Received 14 August 2002 Accepted28 October 2002
Sixty-three rifampicin-resistant (Rifr) isolates of Mycobacterium tuberculosis from Kaohsiung, Taiwan, were analysed for mutations in the core region (69 bp, codons 511533) of the rpoB gene. Some 84.1 % (53/63) of the resistant isolates showed mutations in this region, especially in codons 531 (41.5 %), 526 (18.9 %), 516 (15.1 %) and 533 (7.5 %). Five novel alleles of a total of 16 different types of mutations were identified in Rifr isolates. Ten Rifr isolates (15.9 %) exhibited no mutations in the core region of rpoB. Also, they did not show mutations in another 365 bp fragment (codons 99220) of rpoB. The agar proportion method was used to determine the relationship between the degree of rifampicin resistance and alterations in the core region of rpoB. The results revealed that the mean MIC was 92.38 µg ml-1 for the 53 isolates with a mutation in the core region, whereas the mean MIC of the other 10 isolates without mutations was only 24.8 µg ml-1. This indicates that the isolates with mutations in the core region had higher levels of resistance than those without mutations in this region. IS6110 restriction fragment length polymorphism (RFLP) was used for typing of 55 Rifr M. tuberculosis isolates. Isolates contained two to 19 copies of IS6110, with sizes ranging from 600 to 16 000 bp. The majority (85 %) contained six to 16 copies. No strains lacking IS6110 were found. A total of 54 of 55 RFLP types were defined at the 90 % similarity level. The observation of varied IS6110-associated banding patterns indicates that an outbreak of drug-resistant tuberculosis did not occur in this area.
This article has been cited by other articles:
![]() |
A. Soudani, S. Hadjfredj, M. Zribi, A. Masmoudi, T. Messaoud, H. Tiouri, and C. Fendri Characterization of Tunisian Mycobacterium tuberculosis Rifampin-Resistant Clinical Isolates J. Clin. Microbiol., September 1, 2007; 45(9): 3095 - 3097. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Marme, A. Friedrich, M. Muller, O. Nolte, J. Wolfrum, J. D. Hoheisel, M. Sauer, and J.-P. Knemeyer Identification of single-point mutations in mycobacterial 16S rRNA sequences by confocal single-molecule fluorescence spectroscopy Nucleic Acids Res., July 26, 2006; 34(13): e90 - e90. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Caoili, A. Mayorova, D. Sikes, L. Hickman, B. B. Plikaytis, and T. M. Shinnick Evaluation of the TB-Biochip Oligonucleotide Microarray System for Rapid Detection of Rifampin Resistance in Mycobacterium tuberculosis. J. Clin. Microbiol., July 1, 2006; 44(7): 2378 - 2381. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. O'Sullivan, T. D. McHugh, and S. H. Gillespie Analysis of rpoB and pncA mutations in the published literature: an insight into the role of oxidative stress in Mycobacterium tuberculosis evolution? J. Antimicrob. Chemother., May 1, 2005; 55(5): 674 - 679. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Jou, H.-Y. Chen, C.-Y. Chiang, M.-C. Yu, and I.-J. Su Genetic Diversity of Multidrug-Resistant Mycobacterium tuberculosis Isolates and Identification of 11 Novel rpoB Alleles in Taiwan J. Clin. Microbiol., March 1, 2005; 43(3): 1390 - 1394. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | J MED MICROBIOL | MICROBIOLOGY | J GEN VIROL | ALL SGM JOURNALS |